Viatris Biocon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

California's Office of the Attorney General contends that drugmakers and pharmacy benefit managers work together to “aggressively raise the list price of insulin in lockstep with each other to artificial levels.” Insulin manufacturers deny the allegations, pointing to availability of lower-cost versions of their products. ....

United States , Los Angeles , Mike Mason , Viatris Biocon , Eli Lilly , California Office Of The Attorney General , Los Angeles Superior Court , Corporate Communications Mike Deangelis , Novo Nordisk , Express Scripts , Unfair Competition Law , California Office , Executive Director , Inflation Reduction Act , Insulin Lispro , Express Script , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding ,